Report a Post
You are reporting the following post for review:
"A letter from the White House, signed by Donald Trump, addresses Boehringer Ingelheim and other pharmaceutical manufacturers, demanding they lower prescription drug prices for American patients to Most-Favored-Nation (MFN) levels and repatriate revenues from foreign markets, warning of further action if compliance is not met by September 29, 2025."